[1] Fujita K, Kubota Y, Ishida H, Sasaki Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World Journal of Gastroenterology. 2015;21(43) :12234-12248.
[2] Man F, Goey A, Schaik R, Mathijssen R, Bins S. Individualization of Irinotecan Treatment: A Review of Pharmacokinetics. Pharmacodynamics, and Pharmacogenetics, Clinical pharmacokinetics. 2018;57(10): 1229-1254.
[3] Cheng K, Tseng C, Tzeng C, Leu Y, Cheng T, Wang J, et,al. Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacological Research. 2019;139 :41-49.
[4] Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, et,al. How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?. Molecules. 2017 22(7):1135.
[5] Eng C. Are herbal medicines ripe for the cancer clinic?. Science Translational Medicine. 2010;2(45): 45ps41.
[6] Guan H, Li P, Wang X, Yue J, He Y, Luo X , et,al. Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity. Frontiers in Pharmacology. 2017;8:769.
[7] Lu H, J. Han Q, Xie F, Gong L, Li C. Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer. Integrative Cancer Therapies. 2018;17(4):1109-1114.
[8] Liu C, Liang X, Wei X, Jin Z, Chen F, Tang Q, et,al. Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids. Frontiers in Microbiology. 2019;10:825.
[9] Fan Y, Yi W, Huang H, Mei Z, Feng Z. Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials. Medicine. 2019;98(52):e18512.
[10] Wu Y, Wang D, Yang X, Fu C, Zou L, Zhang J. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Biomed Pharmacother. 2019;109:2252-2261.
[11] Miao W, Wang Q, Bo T, Ye M, Qiao X, Yang W, et,al. Rapid characterization of chemical constituents and rats metabolites of the traditional Chinese patent medicine Gegen-Qinlian-Wan by UHPLC/DAD/qTOF-MS. Journal of Pharmaceutical and Biomedical analysis. 2013;72:99-108.
[12] Newman D. Modern traditional Chinese medicine: Identifying, defining and usage of TCM components. Advances in Pharmacology. 2020;87:113-158.
[13] Zhang C, Lian R, Mahmoodurrahman M, Lai S, Zhao Z, Yu Y. Serum pharmacochemistry for tracking bioactive components by UPLC-Q-TOF-MS/MS combined chromatographic fingerprint for quality assessment of Sanziguben Granule. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 2016;1029:128-136.
[14] Ma F, Xue P, Wang Y, Wang Y, Xue S.Y. Research progress of serum pharmacochemistry of traditional Chinese medicine. China journal of Chinese materia medica. 2017;42(7):1265-1270.
[15] Liu X, Lv M, Huang M, Sun Y, Gao P, Li D. A network pharmacology study on the triterpene saponins from Medicago sativa L. for the treatment of Neurodegenerative diseases. J Food Biochem. 2019;43(8):e12955.
[16] Chen Y, Dong J, Liu J, Xu W, Wei Z, Li Y, et,al. Network Pharmacology-Based Investigation of Protective Mechanism of Aster tataricus on Lipopolysaccharide-Induced Acute Lung Injury, International journal of molecular sciences.2019; 20(3):543 .
[17] Yang L, Li A, Chen M, Yan Y, Liu Y. Comprehensive investigation of mechanism and effective ingredients of Fangji Huangqi Tang by serum pharmacochemistry and network pharmacology. Biomedical Chromatography. 2020;34(4): e4785.
[18] Ling X, Xiang Y, Chen F, Tang Q, Zhang W, Tan X. Intestinal absorption differences of major bioactive compounds of Gegenqinlian Decoction between normal and bacterial diarrheal mini-pigs in vitro and in situ. Journal of Chromatography B-Analytical Technologies In the Biomedical And Life Sciences. 2018;1083:93-101.
[19] Cao Y, Fang S, Yin Z, Fu X, Shang X, Yang W, et,al. Chemical Fingerprint and Multicomponent Quantitative Analysis for the Quality Evaluation of Cyclocarya paliurus Leaves by HPLC-Q-TOF-MS. Molecules. 2017;22(11):1927.
[20] Wang Y, Shen C, Jiang J. Antidepressant active ingredients from herbs and nutraceuticals used in TCM: pharmacological mechanisms and prospects for drug discovery. Pharmacological Research. 2019;150:104520.
[21] Ghahfarokhi M, Shohan M, Shirzad H, Rahimian G, Soltani A, Samani M, et,al. The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis. Pathol Res Pract. 2018; 214(8):1149-1115.
[22] Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe S. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94(2): 329-54.
[23] Gałecki P, Talarowska M. Inflammatory theory of depression. Psychiatria Polska. 2018;52(3):437-447.
[24] Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et, al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Bioscience Trends. 2015; 9(1):16-34.
[25] Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen E, et, al. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2(45):45ra59.
[26] Ryuk J, Lixia M, Cao S, Ko B, Park S. Efficacy and safety of Gegen Qinlian decoction for normalizing hyperglycemia in diabetic patients: A systematic review and meta-analysis of randomized clinical trials. Complementary Therapies in Medicine. 2017;33:6-13.
[27] Zhang J, Li H, Zhang Y, Zhao C, Zhu Y, Han M. Uncovering the Pharmacological Mechanism of Stemazole in the Treatment of Neurodegenerative Diseases Based on a Network Pharmacology Approach. International Journal of Molecular Sciences. 2020;21(2):427.
[28] Shahreza M, Ghadiri N, Mousavi S, Varshosaz J, Green J. A review of network-based approaches to drug repositioning. Briefings in Bioinformatics. 2018;19(5):878-892.
[29] Jain B, Raj U, Varadwaj P. Drug Target Interplay: A Network-based Analysis of Human Diseases and the Drug Targets. Current Topics in Medicinal Chemistry. 2018;18(13):1053-1061.
[30] Muhammad J, Khan A, Ali A, Fang L, Yan J, Xu Q, et, al. Network Pharmacology: Exploring the Resources and Methodologies. Current topics in Medicinal Chemistry. 2018;18(12):949-964.
[31] Lu M, Ji J, Jiang Y, Chen Z, Yuan Z, You Q, Jiang Z. An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis. Sci Rep.2016;6:26585.
[32] Wang Y, Wang H, Qian C, Tang J, Zhou W, Liu X, et, al. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome. Biochem Pharmacol.2016;101:71-86.
[33] Yang Y, Cai X, Yang J, Sun X, Hu C, Yan Z, et, al. Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation. Mol Cancer.2014;6:13-48.
[34] Zhang Y, Yan T, Sun D, Xie C, Wang T, Liu X, et, al. Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis. Free Radic Biol Med. 2020;148:33-41.
[35] Abed D, Goldstein M, Albanyan H, Jin H, Hu L. Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents. Acta Pharmaceutica Sinica. 2015;5(4):285-99.
[36] Deshmukh P, Unni S, Krishnappa G, Padmanabhan B. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophysical Reviews. 2017;9(1) :41-56.
[37] Wu J, Hu Y, Xiang L, Li S, Yuan V, Chen X, et, al. San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review. Frontiers In Pharmacology. 2016; 7:448.
[38] Xu R, Yin J, Zhang Y, Zhang S. Annexin A3 depletion overcomes resistance to oxaliplatin in colorectal cancer via the MAPK signaling pathway. Journal of Cellular Biochemistry. 2019;120(9):14585-14593.
[39] Cao M, Wang P, Sun C, He W, Wang F. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS One. 2013;8(5): e61944.
[40] Yeung Y, Aziz F, Castilla A, Arguelles S. Signaling Pathways in Inflammation and Anti-inflammatory Therapies. Current Pharmaceutical Design. 2018;24(14):1449-1484.
[41] Soleimani A, Rahmani F, Saeedi N, Ghaffarian R, Khazaei M, Ferns G, et, al. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem. 2019;120(12): 19245-19253.
[42] Atiq A, Shal B, Naveed M, Khan A, Ali J, Zeeshan S, et, al. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents. European Journal of Pharmacology. 2019; 843:292-306.
[43] Chen S, Wu S, Li W, Chen X, Dong X, Tan G, et, al. Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches. Molecular Biosystems. 2014;10(12):3310-3321.
[44] Huang Y, Zhu D, Chen X, Chen Q, Luo Z, Liu C, et, al. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway. Oncotarget. 2017;8(25):40264-40275.
[45] Cheng Y, Leng W, Zhang J. Protective Effect of Puerarin Against Oxidative Stress Injury of Neural Cells and Related Mechanisms. Medical Science Monitor. 2016; 22:1244-1249.
[46] Cho S, Choi E. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J Biochem Mol Biol. 2002;35(1):24-27.
[47] Lu J, Fu L, Tang Z, Zhang C, Qin L, Wang J, et, al. Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget. 2016; 7(3):2985-3001.
[48] Wan D, Ouyang H. Baicalin induces apoptosis in human osteosarcoma cell through ROS-mediated mitochondrial pathway. Natural Product Research. 2018;32(16):1996-2000.